Praiseldy Langi Sasongko

160 Chapter 4 16. Sanquin. About Sanquin: organizational units [monograph on the internet]. 2020. https://www.sanquin.org/about-sanquin/ organization/organizational-units. Accessed 20 Jul 2020. 17. Walker WE. Policy analysis: a systematic approach to supporting policymaking in the public sector. J Multicriteria Decis Anal. 2000;9:11–27. 18. Dong C, Schoups G, van de Giesen N. Scenario development for water resource planning and management: a review. Technol Forecast Soc Change. 2013;80:749–61. 19. MeetingSphere. Effective online meetings. Honest opinions. Shared priorities. Great outcomes [monograph on the internet]. 2020. https://www.meetingsphere.com/. Accessed 20 July 2020. 20. Maack JN. Scenario analysis: a tool for task managers. Social development papers: social analysis selected tools and tech- niques. Washington D.C.: Social Development Family of the World Bank; 2001. p. 62–7. 21. Ashley EA. The precision medicine initiative: a new national effort. JAMA. 2015;313:2119–20. 22. Klein HG, Flegel WA, Natanson C. Red blood cell transfusion: precision vs imprecision medicine. JAMA. 2015;314:1557–8. 23. D’Alessandro A, Liumbruno G. Personalised transfusion medicine. Blood Transfus. 2019;17:255–7. 24. Sanquin Communications. Strategie Bloedbank+ 2019–2024 (Internal Report). Amsterdam: Sanquin Communications; 2018. 25. Ivanov D. Predicting the impacts of epidemic outbreaks on global supply chains: a simulation-based analysis on the coro- navirus outbreak (COVID-19/SARS-CoV-2) case. Transp Res E Logist Transp Rev. 2020;136:101922. 26. Goodell JW. COVID-19 and finance: agendas for future research. Financ Res Lett. 2020;35:101512. 27. Nelson R. COVID-19 disrupts vaccine delivery. Lancet Infect Dis. 2020;20:546. 28. Saritas O, Smith JE. The big picture – trends, drivers, wild cards, discontinuities and weak signals. Futures. 2011;43:292–312. 29. Spekman M, Ramondt S, Quee F, Prinsze F, Huis in ‘t Veld E, van den Hurk K, et al. New blood donors in times of crisis: increased donation willingness, particularly among people at high risk for attracting SARS-CoV-2. Transfusion. 2021;1:1–8. 30. Choudhury N, Mathur A, Smit Sibinga CT. COVID-19 pandemic – blood supply challenges and approaches in AATM member countries. ISBT Sci Ser. 2020;15:353–61. 31. Rim JH, Lee SA, Han CH, Yoo J. Transfusion demand in COVID-19 patients from the Korean population: a nationwide study in South Korea. Br J Haematol. 2020;190:e323–e6. 32. Wang Y, Han W, Pan L, Wang C, Liu Y, Hu W, et al. Impact of COVID-19 on blood centres in Zhejiang province China. Vox Sang. 2020;115:502–6.

RkJQdWJsaXNoZXIy MTk4NDMw